Chemical Compound

RDEA-119 S enantiomer|||BAY-86-9766 S enantiomer|||N-[3,4-Difluoro-2-(2-fluoro-4-iodoanilino)-6-methoxyphenyl]-1-[(2S)-2,3-dihydroxypropyl]cyclopropane-1-sulfonamide

CAS Registry Number 923032-37-5
RDEA-119 S enantiomer|||BAY-86-9766 S enantiomer|||N-[3,4-Difluoro-2-(2-fluoro-4-iodoanilino)-6-methoxyphenyl]-1-[(2S)-2,3-dihydroxypropyl]cyclopropane-1-sulfonamide 结构式
Primary record

RDEA-119 S enantiomer|||BAY-86-9766 S enantiomer|||N-[3,4-Difluoro-2-(2-fluoro-4-iodoanilino)-6-methoxyphenyl]-1-[(2S)-2,3-dihydroxypropyl]cyclopropane-1-sulfonamide

库存
9,095 克
纯度
99.4 %
CAS
923032-37-5

化合物标识与属性

CAS
923032-37-5
PubChem CID
44182295
SMILES
COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)NC3=C(C=C(C=C3)I)F)F)F
Canonical SMILES
COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1

名称与同义词

  • Refametinib
  • RDEA119
  • 923032-37-5
  • refametinibum
  • Refamitinib
  • Refametinib [INN]
  • BAY 869766
  • UNII-JPX07AFM0N
  • JPX07AFM0N
  • RDEA 119
  • RDEA-119
  • 3e8n
  • Refametinib (RDEA119)
  • Refametinib R enantiomer
  • Refametinib; RDEA119
  • RefChem:178733
  • MEK Inhibitor RDEA119
  • D03SKL
  • BAY-869766
  • C19H20F3IN2O5S
  • REFAMETINIB [WHO-DD]
  • SCHEMBL345333
  • DTXSID40238961
  • BAY 86-9766
  • BAY 8697661
  • BAY-8697661
  • BAY869766
  • MFCD18633256
  • GTPL7942
  • orb1300596
  • Refametinib (BAY86-9766)
  • BAY86-9766
  • BAY8697661
  • CHEMBL1236682
  • SCHEMBL29358040
  • SCHEMBL29368551
  • SCHEMBL29398471
  • BAY-86-9766
  • DTXCID90161452
  • Refametinib (BAY86-9766)?
  • CHEBI:231602
  • RDSACQWTXKSHJT-NSHDSACASA-N
  • BDBM520650
  • GLXC-90213
  • AOB87134
  • EX-A2481
  • Refametinib (RDEA119, Bay 86-9766)
  • 2254AH
  • NSC800864
  • s1089
  • ZINC39187987
  • BAY 869766;RDEA119
  • AKOS025401896
  • CCG-270103
  • CS-1818
  • DB06309
  • EBC-221124
  • NSC-800864
  • BAY 86-9766;RDEA119
  • RDEA119(BAY 869766)
  • NCGC00188380-01
  • NCGC00188380-02
  • NCGC00188380-03
  • NCGC00188380-11
  • (S)-N-(3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide
  • 4CA-0257
  • AC-26962
  • AS-16994
  • BAY 86-97661
  • DA-67137
  • FR104239
  • HY-14691
  • B1034
  • B1267
  • NS00072392
  • SW218136-2
  • J3.661.482J
  • A11264
  • F51934
  • US11147816, Refametinib (RDEA119, Bay
  • Z-3246
  • N-[3,4-difluoro-2-(2-fluoro-4-iodoanilino)-6-methoxyphenyl]-1-[(2S)-2,3-dihydroxypropyl]cyclopropane-1-sulfonamide
  • A857418
  • BRD-K85751432-001-03-3
  • Q27088526
  • 923032-38-6
  • BAY 869766;BAY 86-97661;RDEA-119;RDEA119
  • (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide
  • Cyclopropanesulfonamide, N-(3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)-6-methoxyphenyl)-1-((2S)-2,3-dihydroxypropyl)-
  • N-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl}-1-[(2S)-2,3-dihydroxypropyl]cyclopropane-1-sulfonamide
  • N-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl}-1-[(2S)-2,3-dihydroxypropyl]cyclopropanesulfonamide
  • 923032-36-4
  • CYCLOPROPANESULFONAMIDE, N-(3,4-DIFLUORO-2-((2-FLUORO-4-IODOPHENYL)AMINO)-6-METHOXYPHENYL)-1-((2S)-2,3-DIHYDROXYPROPYL0-
  • N-(3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)-6-methoxyphenyl)-1-((2S)-2,3-dihydroxypropyl)cyclopropane-1-sulfonamide
  • N-(3,4-difluoro-2-(2-fluoro-4-iodoanilino)-6-methoxyphenyl)-1-((2S)-2,3-dihydroxypropyl)cyclopropane-1-sulfonamide
  • N-[2-(2-Fluoro-4-iodoanilino)-3,4-difluoro-6-methoxyphenyl]-1-[(S)-2,3-dihydroxypropyl]cyclopropanesulfonamide
  • N-[3,4-difluoro-2-(2-fluoro-4-iodo-anilino)-6-methoxy-phenyl]-1-[(2S)-2,3-dihydroxypropyl]cyclopropanesulfonamide
  • N-[3,4-Difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl]-1-[(2S)-2,3-dihydroxypropyl]cyclopropanesulfonamide
  • RDEA-119 S enantiomer|||BAY-86-9766 S enantiomer|||N-[3,4-Difluoro-2-(2-fluoro-4-iodoanilino)-6-methoxyphenyl]-1-[(2S)-2,3-dihydroxypropyl]cyclopropane-1-sulfonamide
  • VRA